REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Latinmed S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Latinmed S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Latinmed S.A. is an enterprise based in Ecuador. Its main office is in Guayaquil. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on November 11, 2008. 2 (2023) employees currently work for Latinmed S.A.. The latest financial highlights indicate a net sales revenue increase of 308.56% in 2023. Over the same period, its total assets grew by 152.66%. The enterprise’s net profit margin decreased by 21.9% in 2023.

Headquarters
Cdla. Kennedy 652, Edificio Kennedy Plaza Bldg.
Guayaquil; Guayas;

Contact Details: Purchase the Latinmed S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Latinmed S.A. report to view the information.
Outstanding Shares:
Purchase the Latinmed S.A. report to view the information.
Registered Capital:
Purchase the Latinmed S.A. report to view the information.
Incorporation Date:
November 11, 2008
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
98%
Purchase this report to view the information.
2%
Company Performance
Financial values in the chart are available after Latinmed S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
308.56%▲
Total operating revenue
308.56%▲
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-32.89%▼
Total assets
152.66%▲
Total equity
38.95%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-21.9%▼
Return on Equity (ROE)
-30.01%▼
Quick Ratio
-0.11%▼
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo